Germline counterparts of oncogenic mutations: who gives a JAK?.

Germline counterparts of oncogenic mutations: who gives a JAK?.

Bibliografski detalji
Glavni autori:	Mead, A, Constantinescu, SN, Jacobsen, SE
Format:	Journal article
Jezik:	English
Izdano:	2013

Slični predmeti

Germline JAK2 mutation in a family with hereditary thrombocytosis.
od: Mead, A, i dr.
Izdano: (2012)

Impact of isolated germline JAK2V617I mutation on human hematopoiesis.
od: Mead, A, i dr.
Izdano: (2013)

Germline activating JAK2-mutation in a family with hereditary thrombocytosis
od: Mead, A, i dr.
Izdano: (2012)

Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors
od: Tekla Hornakova, i dr.
Izdano: (2011-06-01)

Germline Activating JAK2 V617I Mutation, in a Family with Hereditary Thrombocytosis
od: Mead, A, i dr.
Izdano: (2011)

Novel germline JAK2R715T mutation causing PV-like erythrocytosis in 3 generations. Amelioration by Ropeg-Interferon
od: Song, J, i dr.
Izdano: (2024)

Germline JAK2 L611S mutation in a child with thrombocytosis
od: Bernard Aral, i dr.
Izdano: (2018-08-01)

Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients
od: Jie Yang, i dr.
Izdano: (2021-04-01)

Oncogenic Cooperation Between IL7R-JAK-STAT Pathway Mutations
od: Inge Lodewijckx, i dr.
Izdano: (2021-09-01)

P996: A NOVEL GERMLINE GAIN-OF-FUNCTION JAK2 MUTATION: L604F
od: Lukas Dvoracek, i dr.
Izdano: (2023-08-01)

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia
od: Zhuanghui Hao, i dr.
Izdano: (2024-01-01)

Degrading JAK2 in ALL by ruxolitinib-based PROTACs
od: Constantinescu, SN, i dr.
Izdano: (2021)

A Vietnamese MEN2A syndrome patient with C634G germline mutation of the RET proto-oncogene
od: Pham Le Bich Hang, i dr.
Izdano: (2019-12-01)

Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis
od: Derek W. Brown, i dr.
Izdano: (2022-09-01)

Comparing the quality of life in adults who stutter with their normal counterparts
od: Banafsheh Mansuri, i dr.
Izdano: (2013-06-01)

Counterpart
od: Netherlands Universities Foundation for International Cooperation
Izdano: (1984)

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.
od: Reckzeh, K, i dr.
Izdano: (2012)

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.
od: Reckzeh, K, i dr.
Izdano: (2012)

JAK signaling regulates germline cyst breakdown and primordial follicle formation in mice
od: Kun Huang, i dr.
Izdano: (2018-01-01)

Comparing the Lifestyle of Mothers who Have Memorized the Quran and their Counterparts in Tehran
od: Ahad Navidi, i dr.
Izdano: (2017-11-01)

Germline Variants in Proto-Oncogenes and Tumor Suppressor Genes in Women with Cervical Cancer
od: Ksenia Lenkova, i dr.
Izdano: (2024-10-01)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction.
od: Reina E Ito, i dr.
Izdano: (2021-01-01)

Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel <I>GFI1B</I> germline mutation
od: Michela Faleschini, i dr.
Izdano: (2021-01-01)

Counterparts and actuality
od: Fara, M, i dr.
Izdano: (2005)

Counterparts and actuality
od: Fara, M, i dr.
Izdano: (2005)

Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase Domain
od: Juuli Raivola, i dr.
Izdano: (2018-12-01)

A germline RET proto-oncogene mutation in multiple members of an Arab family with variable onset of MEN type 2A-associated clinical manifestations
od: Makia Marafie, i dr.
Izdano: (2017-04-01)

Germline Mutations for Kidney Volume in ADPKD
od: Hiroshi Kataoka, i dr.
Izdano: (2022-03-01)

"Women Who Don't Give a Crap".
od: Holly Tabor
Izdano: (2015-12-01)

Decoding germline de novo point mutations
od: Goriely, A
Izdano: (2016)

Germline CDH1 mutations in bilateral lobular carcinoma in situ.
od: Petridis, C, i dr.
Izdano: (2014)

RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability
od: Edwin Chen, i dr.
Izdano: (2015-12-01)

New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis
od: Florence Pasquier, i dr.
Izdano: (2018-04-01)

Actuality for counterpart theorists
od: Russell, J
Izdano: (2013)

Counterpart Theory and Actuality
od: Milford, J
Izdano: (2024)

JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
od: Inge Govaerts, i dr.
Izdano: (2019-12-01)

“3D Counterpart Analysis”: A Novel Method for Enlow’s Counterpart Analysis on CBCT
od: Michele D’Attilio, i dr.
Izdano: (2022-10-01)

Monitoring of radiation-induced germline mutation in humans
od: YE Dubrova
Izdano: (2003-09-01)

Germline PTEN mutations are rare and highly penetrant
od: Rustad Cecilie F, i dr.
Izdano: (2006-12-01)

Sex differences in oncogenic mutational processes
od: Li, CH, i dr.
Izdano: (2020)